• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Investigation of the substrate specificity of K5 lyase A from K5A bacteriophage.研究 K5A 噬菌体 K5 裂解酶 A 的底物特异性。
Glycobiology. 2013 Jan;23(1):132-41. doi: 10.1093/glycob/cws136. Epub 2012 Sep 26.
2
Cloning, expression, and purification of the K5 capsular polysaccharide lyase (KflA) from coliphage K5A: evidence for two distinct K5 lyase enzymes.来自大肠杆菌噬菌体K5A的K5荚膜多糖裂解酶(KflA)的克隆、表达及纯化:两种不同K5裂解酶的证据
J Bacteriol. 2000 Jul;182(13):3761-6. doi: 10.1128/JB.182.13.3761-3766.2000.
3
New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin.通过使用来自大肠杆菌的K5多糖和2-O-去硫酸化肝素的合成衍生物揭示了来自肝素黄杆菌的肝素和硫酸乙酰肝素裂解酶特异性的新见解。
Glycoconj J. 1999 Jun;16(6):265-70. doi: 10.1023/a:1007057826179.
4
A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase.基于K5裂解酶新特异性的硫酸乙酰肝素结构域结构新模型。
J Biol Chem. 2004 Jun 25;279(26):27239-45. doi: 10.1074/jbc.M401774200. Epub 2004 Mar 26.
5
The K5 lyase KflA combines a viral tail spike structure with a bacterial polysaccharide lyase mechanism.K5 裂解酶 KflA 将病毒尾部刺突结构与细菌多糖裂解酶机制结合在一起。
J Biol Chem. 2010 Jul 30;285(31):23963-9. doi: 10.1074/jbc.M110.127571. Epub 2010 Jun 2.
6
Relative susceptibilities of the glucosamine-glucuronic acid and N-acetylglucosamine-glucuronic acid linkages to heparin lyase III.葡萄糖胺 - 葡萄糖醛酸和N - 乙酰葡萄糖胺 - 葡萄糖醛酸键对肝素酶III的相对敏感性。
Biochemistry. 2004 Jul 6;43(26):8590-9. doi: 10.1021/bi036250k.
7
Biophysical investigation of recombinant K5 lyase: structural implications of substrate binding and processing.重组K5裂解酶的生物物理研究:底物结合与加工的结构意义
Biochim Biophys Acta. 2007 Jan;1774(1):72-7. doi: 10.1016/j.bbapap.2006.10.017. Epub 2006 Nov 10.
8
Analysis of the enzymatic cleavage (beta elimination) of the capsular K5 polysaccharide of Escherichia coli by the K5-specific coliphage: reexamination.K5特异性大肠杆菌噬菌体对大肠杆菌荚膜K5多糖的酶促裂解(β消除)分析:重新审视
J Bacteriol. 1996 Aug;178(15):4747-50. doi: 10.1128/jb.178.15.4747-4750.1996.
9
Recombinant Escherichia coli K5 strain with the deletion of waaR gene decreases the molecular weight of the heparosan capsular polysaccharide.缺失 waaR 基因的重组大肠杆菌 K5 菌株降低了肝素聚糖荚膜多糖的分子量。
Appl Microbiol Biotechnol. 2016 Sep;100(18):7877-85. doi: 10.1007/s00253-016-7511-y. Epub 2016 Apr 14.
10
Distinct substrate specificities of bacterial heparinases against N-unsubstituted glucosamine residues in heparan sulfate.细菌类肝素酶对硫酸乙酰肝素中N-未取代葡糖胺残基的不同底物特异性。
J Biol Chem. 2005 Apr 22;280(16):15742-8. doi: 10.1074/jbc.M501102200. Epub 2005 Feb 10.

引用本文的文献

1
Phage-encoded carbohydrate-interacting proteins in the human gut.人类肠道中噬菌体编码的碳水化合物相互作用蛋白。
Front Microbiol. 2023 Jan 6;13:1083208. doi: 10.3389/fmicb.2022.1083208. eCollection 2022.
2
Reprogramming bacteriophage host range: design principles and strategies for engineering receptor binding proteins.重新编程噬菌体宿主范围:工程受体结合蛋白的设计原则和策略。
Curr Opin Biotechnol. 2021 Apr;68:272-281. doi: 10.1016/j.copbio.2021.02.006. Epub 2021 Mar 18.
3
Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract.靶向哺乳动物聚糖可增强噬菌体在胃肠道中的捕食作用。
mBio. 2021 Feb 9;12(1):e03474-20. doi: 10.1128/mBio.03474-20.
4
Identification of three podoviruses infecting Klebsiella encoding capsule depolymerases that digest specific capsular types.鉴定出三种感染产酸克雷伯菌的短尾噬菌体,编码能消化特定荚膜类型的荚膜降解酶。
Microb Biotechnol. 2019 May;12(3):472-486. doi: 10.1111/1751-7915.13370. Epub 2019 Jan 31.
5
Uncovering the Catalytic Direction of Chondroitin AC Exolyase: FROM THE REDUCING END TOWARDS THE NON-REDUCING END.揭示硫酸软骨素AC外切酶的催化方向:从还原端到非还原端。
J Biol Chem. 2016 Feb 26;291(9):4399-406. doi: 10.1074/jbc.C115.708396. Epub 2016 Jan 7.
6
De novo synthesis of a narrow size distribution low-molecular-weight heparin.窄尺寸分布低分子量肝素的从头合成。
Glycobiology. 2014 May;24(5):476-86. doi: 10.1093/glycob/cwu016. Epub 2014 Mar 13.

本文引用的文献

1
Chemoenzymatic synthesis of uridine diphosphate-GlcNAc and uridine diphosphate-GalNAc analogs for the preparation of unnatural glycosaminoglycans.酶促化学合成尿苷二磷酸-N-乙酰葡糖胺和尿苷二磷酸-N-乙酰半乳糖胺类似物用于制备非天然糖胺聚糖。
J Org Chem. 2012 Feb 3;77(3):1449-56. doi: 10.1021/jo202322k. Epub 2012 Jan 12.
2
Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3'-phosphoadenosine-5'-phosphosulfate.在乳酸克鲁维酵母中表达硫酸乙酰肝素转移酶及制备 3'-磷酸腺苷-5'-磷酸硫酸。
Glycobiology. 2011 Jun;21(6):771-80. doi: 10.1093/glycob/cwr001. Epub 2011 Jan 11.
3
Structural and mechanistic classification of uronic acid-containing polysaccharide lyases.含糖醛酸多糖裂解酶的结构和机制分类。
Glycobiology. 2010 Dec;20(12):1547-73. doi: 10.1093/glycob/cwq122. Epub 2010 Aug 30.
4
Chemoenzymatic design of heparan sulfate oligosaccharides.肝素硫酸寡糖的化学酶法设计。
J Biol Chem. 2010 Oct 29;285(44):34240-9. doi: 10.1074/jbc.M110.159152. Epub 2010 Aug 21.
5
The K5 lyase KflA combines a viral tail spike structure with a bacterial polysaccharide lyase mechanism.K5 裂解酶 KflA 将病毒尾部刺突结构与细菌多糖裂解酶机制结合在一起。
J Biol Chem. 2010 Jul 30;285(31):23963-9. doi: 10.1074/jbc.M110.127571. Epub 2010 Jun 2.
6
Unraveling the specificity of heparanase utilizing synthetic substrates.利用合成底物阐明肝素酶的特异性。
J Biol Chem. 2010 May 7;285(19):14504-13. doi: 10.1074/jbc.M110.104166. Epub 2010 Feb 24.
7
Investigating the molecular basis for the virulence of Escherichia coli K5 by nuclear magnetic resonance analysis of the capsule polysaccharide.通过对荚膜多糖进行核磁共振分析来研究大肠杆菌K5毒力的分子基础。
J Mol Microbiol Biotechnol. 2009;17(2):71-82. doi: 10.1159/000215933. Epub 2009 Apr 25.
8
Crystal structure of Escherichia coli phage HK620 tailspike: podoviral tailspike endoglycosidase modules are evolutionarily related.大肠杆菌噬菌体HK620尾刺的晶体结构:肌尾噬菌体尾刺内切糖苷酶模块具有进化相关性。
Mol Microbiol. 2008 Jul;69(2):303-16. doi: 10.1111/j.1365-2958.2008.06311.x.
9
Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.采用酶促组合方法鉴定抗凝血硫酸乙酰肝素结构。
Chem Biol. 2007 Sep;14(9):986-93. doi: 10.1016/j.chembiol.2007.07.015.
10
The structures of bacteriophages K1E and K1-5 explain processive degradation of polysaccharide capsules and evolution of new host specificities.噬菌体K1E和K1-5的结构解释了多糖荚膜的持续性降解以及新宿主特异性的进化。
J Mol Biol. 2007 Aug 17;371(3):836-49. doi: 10.1016/j.jmb.2007.05.083. Epub 2007 Jun 2.

研究 K5A 噬菌体 K5 裂解酶 A 的底物特异性。

Investigation of the substrate specificity of K5 lyase A from K5A bacteriophage.

机构信息

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.

出版信息

Glycobiology. 2013 Jan;23(1):132-41. doi: 10.1093/glycob/cws136. Epub 2012 Sep 26.

DOI:10.1093/glycob/cws136
PMID:23019155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3505012/
Abstract

K5 lyase A (KflA) is a tailspike protein from the K5A phage that catalyzes the degradation of the capsule polysaccharide of K5 strains of Escherichia coli. The K5 E. coli capsule polysaccharide, also known as heparosan, is composed of the disaccharide repeating unit of [-4)-GlcA-β(1,4)-GlcNAc-α(1-] and therefore identical to the biological precursor of heparin and heparan sulfate (HS). KflA could supplement the heparin lyases for heparin and HS analysis. The first part of this study aimed to clarify ambiguity resulting from the revision of the KflA amino acid sequence in 2010 from that published in 2000. We found that only the expression of the updated sequence gave a soluble active enzyme, which produced heparosan degradation products similar to those of previous studies. Next, we examined the specificity of KflA toward heparosan oligosaccharides of varying sizes, all containing a single N-sulfated glucosamine (GlcNS) residue. The presence of GlcNS in an octasaccharide and a nonasaccharide chain directed cleavage by KflA to a single position at the reducing end of the substrate. However, an N-sulfated decasaccharide exhibited extensive cleavage at the nonreducing end of the chain, illustrating a distinct change in the cleavage pattern of KflA toward substrates of differing sizes. Because KflA is able to cleave a substrate containing isolated GlcNS residues, this enzyme could be used for the analysis of low-sulfate content HS domains.

摘要

K5 溶菌酶 A(KflA)是 K5A 噬菌体的尾刺蛋白,可催化降解大肠杆菌 K5 株的荚膜多糖。大肠杆菌 K5 荚膜多糖,也称为肝素聚糖,由二糖重复单元[-4)-GlcA-β(1,4)-GlcNAc-α(1-]组成,因此与肝素和硫酸乙酰肝素(HS)的生物前体相同。KflA 可以补充肝素酶用于肝素和 HS 的分析。本研究的第一部分旨在澄清 2010 年对 KflA 氨基酸序列的修订所产生的歧义,该修订与 2000 年发表的序列不同。我们发现,只有表达更新后的序列才能产生可溶性活性酶,该酶产生的肝素聚糖降解产物与先前研究相似。接下来,我们研究了 KflA 对不同大小的肝素聚糖寡糖的特异性,所有这些寡糖都含有单个 N-硫酸化葡萄糖胺(GlcNS)残基。在八糖和九糖链中存在 GlcNS 时,KflA 在底物的还原端将其切割到单一位置。然而,N-硫酸化的十糖在链的非还原端表现出广泛的切割,这说明了 KflA 对不同大小的底物的切割模式发生了明显变化。由于 KflA 能够切割含有分离的 GlcNS 残基的底物,因此该酶可用于分析低硫酸化含量的 HS 结构域。